ChemLifeIntel
Access

Willa Pore Perfector (Salicylic Acid 2%) pads

TRACKED

CASHSN
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
14
Manufacturers monitored
38
Intelligence briefs
3
Active regulatory actions
₹2,800 Cr
Est. India export value

INTELLIGENCE

Showing 1 of 1 briefs for Willa Pore Perfector (Salicylic Acid 2%) pads
REGULATORY INTELLIGENCE·Recall

Milbar Laboratories' Salicylic Acid Pads Recall Signals Persistent GMP Challenges for OTC Drug Manufacturers

Milbar Laboratories, Inc. initiated a Class II recall (D-0093-2021) for 2,638 jars of Willa Pore Perfector (Salicylic Acid 2%) pads due to GMP deviations. This event, now terminated, underscores critical quality control vulnerabilities in OTC drug manufacturing and global supply chains. Procurement and regulatory teams must scrutinize supplier compliance to mitigate similar disruptions and ensure product integrity.

90-Day Activity
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
2020-11-25